Although hydrophilic small molecule drugs are widely used in the clinic, their rapid
clearance, suboptimal biodistribution, low intracellular absorption and toxicity can limit their …

Breast cancer is the most prevalent non-cutaneous malignancy in women, with greater than
a million new cases every year. In the last decennium, numerous diagnostic and treatment …

The therapeutic efficacy of systemic drug-delivery vehicles depends on their ability to evade
the immune system, cross the biological barriers of the body and localize at target tissues …

Now days, breast cancer is the most frequently diagnosed life-threatening cancer in women
and the leading cause of cancer death among women. Since last two decades, researches …

The emergence of nanomedicine drugs as a result of the fast advancement of
nanotechnology offers enormous potential for improving cancer treatment strategies. The …

Nanotechnology applications in medicine, termed as nanomedicine, have introduced a
number of nanoparticles of variable chemistry and architecture for cancer imaging and …

Breast cancer (BC) is amongst the most lethal cancer among females and conventional
treatment methods like surgery, radiotherapy and chemotherapy are not effective enough as …

Breast cancer is the most common type of malignancy diagnosed in women. In the
metastatic setting this disease is still uncurable. Taxanes represent an important class of …

Breast Cancer is the most common cancer in women worldwide. Recently bioactive plant
products, namely phytochemicals are being been explored by researchers for their …

Background: The application of nanotechnology in the medical field is called nanomedicine.
Nowadays, this new branch of science is a point of interest for many investigators due to the …